[Form 4] GoHealth, Inc. Insider Trading Activity
Kotte Vijay, identified as a director and Chief Executive Officer of GoHealth, Inc. (GOCO), was granted 218,551 restricted stock units on 08/07/2025 under a First Amendment to his employment agreement. The restricted stock units vest in three annual installments, with the first installment vesting on 08/07/2026. Following the reported transaction, the filing shows beneficial ownership of 1,347,396 shares of Class A common stock, which includes 1,798 shares purchased under the company芒鈧劉s Employee Stock Purchase Plan on 06/30/2025. The filing also corrects prior disclosures by reducing previously reported holdings by 94,444 shares that were subject to unmet performance conditions.
Kotte Vijay, identificato come membro del consiglio e Amministratore Delegato di GoHealth, Inc. (GOCO), ha ricevuto 218,551 unit脿 azionarie vincolate il 08/07/2025 a seguito di un primo emendamento al suo contratto di lavoro. Le unit脿 azionarie maturano in tre tranche annuali, con la prima tranche che matura il 08/07/2026. A seguito della transazione segnalata, la comunicazione indica una titolarit脿 effettiva di 1,347,396 azioni di Classe A, che include 1,798 azioni acquistate tramite il Piano di Acquisto Azionario per i Dipendenti della societ脿 il 06/30/2025. La comunicazione corregge inoltre precedenti divulgazioni riducendo di 94,444 azioni le partecipazioni precedentemente riportate, relative a condizioni di performance non soddisfatte.
Kotte Vijay, identificado como director y consejero delegado de GoHealth, Inc. (GOCO), recibi贸 218,551 unidades de acciones restringidas el 08/07/2025 en virtud de una primera modificaci贸n de su contrato de trabajo. Las unidades se consolidan en tres pagos anuales, con el primero que vence el 08/07/2026. Tras la operaci贸n comunicada, el informe muestra una titularidad beneficiaria de 1,347,396 acciones de Clase A, que incluye 1,798 acciones adquiridas mediante el Plan de Compra de Acciones para Empleados de la compa帽铆a el 06/30/2025. El informe tambi茅n corrige divulgaciones anteriores reduciendo en 94,444 acciones las posiciones previamente informadas que estaban sujetas a condiciones de rendimiento no cumplidas.
Kotte Vijay電� GoHealth, Inc. (GOCO)鞚� 鞚挫偓 瓴� 斓滉碃瓴届榿毂呾瀯鞛愲 頇曥澑霅橂┌, 瓿犾毄瓿勳暯鞐� 雽�頃� 觳� 氩堨Ц 靾橃爼鞎堨棎 霐半澕 08/07/2025鞐� 218,551臧滌潣 鞝滍暅攵�鞐� 欤检嫕雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 鞚� RSU電� 3雲� 霃欖晥 鞐瓣皠 1須岇敥 靹� 彀鞐� 瓯胳硱 旆摑霅橂┌, 觳� 氩堨Ц 攵勴暊攵勳潃 08/07/2026鞐� 旆摑霅╇媹雼�. 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 1,347,396欤检潣 韥措灅鞀� A 鞁れ鞝� 氤挫湢臧� 旮办灛霅橃柎 鞛堨溂氅�, 鞚� 欷戩棎電� 1,798欤缄皜 06/30/2025鞐� 須岇偓鞚� 膦呾梾鞗� 欤检嫕 毵れ垬 瓿勴殟鞚� 韱淀暣 毵れ垬霅� 瓴冹瀰雼堧嫟. 鞝滌稖靹滊電� 霕愴暅 於╈”霅橃 鞎婌潃 靹标臣 臁瓣贝鞐� 頃措嫻頃橂姅 94,444欤茧ゼ 欷勳棳 鞚挫爠鞐� 氤搓碃霅� 氤挫湢霟夓潉 鞝曥爼頃橁碃 鞛堨姷雼堧嫟.
Kotte Vijay, identifi茅 comme administrateur et directeur g茅n茅ral de GoHealth, Inc. (GOCO), s'est vu attribuer 218,551 unit茅s d'actions restreintes le 08/07/2025 dans le cadre d'un premier avenant 脿 son contrat de travail. Les unit茅s d'actions sont soumises 脿 une p茅riode de vesting en trois versements annuels, le premier arrivant 脿 茅ch茅ance le 08/07/2026. 脌 la suite de l'op茅ration d茅clar茅e, le dossier indique une d茅tention b茅n茅ficiaire de 1,347,396 actions de Classe A, incluant 1,798 actions achet茅es via le Plan d'Achat d'Actions des Employ茅s de la soci茅t茅 le 06/30/2025. Le dossier corrige 茅galement des divulgations ant茅rieures en r茅duisant de 94,444 actions les positions pr茅c茅demment signal茅es qui 茅taient soumises 脿 des conditions de performance non remplies.
Kotte Vijay, als Director und Chief Executive Officer von GoHealth, Inc. (GOCO) benannt, erhielt am 08/07/2025 218,551 Restricted Stock Units im Rahmen einer ersten 脛nderung seines Arbeitsvertrags. Die Restricted Stock Units werden in drei j盲hrlichen Tranchen freigegeben, wobei die erste Tranche am 08/07/2026 zur Verf眉gung steht. Nach der gemeldeten Transaktion weist die Meldung ein wirtschaftliches Eigentum von 1,347,396 Aktien der Klasse A aus, darunter 1,798 Aktien, die am 06/30/2025 眉ber den Aktienkaufplan f眉r Mitarbeiter des Unternehmens erworben wurden. Die Meldung korrigiert au脽erdem fr眉here Angaben, indem zuvor gemeldete Best盲nde um 94,444 Aktien reduziert werden, die an nicht erf眉llte Leistungsbedingungen gebunden waren.
- CEO equity grant disclosed: Reporting Person was granted 218,551 restricted stock units under an employment amendment.
- Ownership correction made: Prior overstatement was reduced by 94,444 shares, improving accuracy of insider holdings.
- ESPP participation: Filing notes 1,798 shares purchased under the Employee Stock Purchase Plan on 06/30/2025.
- Prior reporting error: Earlier Form 4s overstated beneficial ownership by 94,444 shares due to unmet performance conditions.
- Restricted stock units not immediately available: The 218,551 RSUs vest in three annual installments with the first vesting on 08/07/2026, so they are not presently transferable.
Insights
TL;DR: CEO granted 218,551 RSUs with multi-year vesting; prior Form 4s were corrected for a 94,444-share overstatement.
The grant formalizes equity compensation under an employment amendment and is structured with three annual vesting installments, aligning compensation timing with future service or performance periods. The filing's explicit correction of a 94,444-share overstatement improves disclosure accuracy but raises questions about prior reporting controls. Overall, this is a routine executive compensation disclosure with governance implications tied to the corrected historical reporting.
TL;DR: 218,551 RSUs awarded to the CEO, not immediately vested; includes ESPP purchase and a correction to prior ownership figures.
From a pay-structure perspective, the award is delivered as restricted stock units priced at $0 and scheduled to vest over three years, which delays economic benefit to the recipient. The inclusion of 1,798 ESPP shares is immaterial in size but is disclosed. The corrected reduction of 94,444 shares indicates previous performance conditions were not met and were appropriately removed from outstanding beneficial holdings.
Kotte Vijay, identificato come membro del consiglio e Amministratore Delegato di GoHealth, Inc. (GOCO), ha ricevuto 218,551 unit脿 azionarie vincolate il 08/07/2025 a seguito di un primo emendamento al suo contratto di lavoro. Le unit脿 azionarie maturano in tre tranche annuali, con la prima tranche che matura il 08/07/2026. A seguito della transazione segnalata, la comunicazione indica una titolarit脿 effettiva di 1,347,396 azioni di Classe A, che include 1,798 azioni acquistate tramite il Piano di Acquisto Azionario per i Dipendenti della societ脿 il 06/30/2025. La comunicazione corregge inoltre precedenti divulgazioni riducendo di 94,444 azioni le partecipazioni precedentemente riportate, relative a condizioni di performance non soddisfatte.
Kotte Vijay, identificado como director y consejero delegado de GoHealth, Inc. (GOCO), recibi贸 218,551 unidades de acciones restringidas el 08/07/2025 en virtud de una primera modificaci贸n de su contrato de trabajo. Las unidades se consolidan en tres pagos anuales, con el primero que vence el 08/07/2026. Tras la operaci贸n comunicada, el informe muestra una titularidad beneficiaria de 1,347,396 acciones de Clase A, que incluye 1,798 acciones adquiridas mediante el Plan de Compra de Acciones para Empleados de la compa帽铆a el 06/30/2025. El informe tambi茅n corrige divulgaciones anteriores reduciendo en 94,444 acciones las posiciones previamente informadas que estaban sujetas a condiciones de rendimiento no cumplidas.
Kotte Vijay電� GoHealth, Inc. (GOCO)鞚� 鞚挫偓 瓴� 斓滉碃瓴届榿毂呾瀯鞛愲 頇曥澑霅橂┌, 瓿犾毄瓿勳暯鞐� 雽�頃� 觳� 氩堨Ц 靾橃爼鞎堨棎 霐半澕 08/07/2025鞐� 218,551臧滌潣 鞝滍暅攵�鞐� 欤检嫕雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 鞚� RSU電� 3雲� 霃欖晥 鞐瓣皠 1須岇敥 靹� 彀鞐� 瓯胳硱 旆摑霅橂┌, 觳� 氩堨Ц 攵勴暊攵勳潃 08/07/2026鞐� 旆摑霅╇媹雼�. 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滊鞐愲姅 1,347,396欤检潣 韥措灅鞀� A 鞁れ鞝� 氤挫湢臧� 旮办灛霅橃柎 鞛堨溂氅�, 鞚� 欷戩棎電� 1,798欤缄皜 06/30/2025鞐� 須岇偓鞚� 膦呾梾鞗� 欤检嫕 毵れ垬 瓿勴殟鞚� 韱淀暣 毵れ垬霅� 瓴冹瀰雼堧嫟. 鞝滌稖靹滊電� 霕愴暅 於╈”霅橃 鞎婌潃 靹标臣 臁瓣贝鞐� 頃措嫻頃橂姅 94,444欤茧ゼ 欷勳棳 鞚挫爠鞐� 氤搓碃霅� 氤挫湢霟夓潉 鞝曥爼頃橁碃 鞛堨姷雼堧嫟.
Kotte Vijay, identifi茅 comme administrateur et directeur g茅n茅ral de GoHealth, Inc. (GOCO), s'est vu attribuer 218,551 unit茅s d'actions restreintes le 08/07/2025 dans le cadre d'un premier avenant 脿 son contrat de travail. Les unit茅s d'actions sont soumises 脿 une p茅riode de vesting en trois versements annuels, le premier arrivant 脿 茅ch茅ance le 08/07/2026. 脌 la suite de l'op茅ration d茅clar茅e, le dossier indique une d茅tention b茅n茅ficiaire de 1,347,396 actions de Classe A, incluant 1,798 actions achet茅es via le Plan d'Achat d'Actions des Employ茅s de la soci茅t茅 le 06/30/2025. Le dossier corrige 茅galement des divulgations ant茅rieures en r茅duisant de 94,444 actions les positions pr茅c茅demment signal茅es qui 茅taient soumises 脿 des conditions de performance non remplies.
Kotte Vijay, als Director und Chief Executive Officer von GoHealth, Inc. (GOCO) benannt, erhielt am 08/07/2025 218,551 Restricted Stock Units im Rahmen einer ersten 脛nderung seines Arbeitsvertrags. Die Restricted Stock Units werden in drei j盲hrlichen Tranchen freigegeben, wobei die erste Tranche am 08/07/2026 zur Verf眉gung steht. Nach der gemeldeten Transaktion weist die Meldung ein wirtschaftliches Eigentum von 1,347,396 Aktien der Klasse A aus, darunter 1,798 Aktien, die am 06/30/2025 眉ber den Aktienkaufplan f眉r Mitarbeiter des Unternehmens erworben wurden. Die Meldung korrigiert au脽erdem fr眉here Angaben, indem zuvor gemeldete Best盲nde um 94,444 Aktien reduziert werden, die an nicht erf眉llte Leistungsbedingungen gebunden waren.
FAQ
What did GoHealth (GOCO) disclose in this Form 4?
How do the granted restricted stock units (RSUs) vest?
Was there a correction to prior insider filings for GOCO?
Does the Form 4 report any purchases under an employee plan?
How many shares does the reporting person beneficially own after the transaction?
